Our experimental results from colony formation assay demonstrate that the combination of cyclic peptides and cisplatin has a strong inhibitory effect on cervical cancer, providing a possible new treatment solution for overcoming chemotherapy and PD-1/PD-L1 inhibitor resistance. This evidence concerns the gene CD274 and cervical carcinoma.